Highly drug-resistant pathogens implicated in burn-associated bacteremia in an Iraqi burn care unit

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Ronat, Jean Baptiste ^a   Kakol, Jabar ^b   Khoury, Marwan N ^c   Berthelot, Mathilde ^a   Yun, Oliver ^a   Brown, Vincent ^a   Murphy, Richard A ^a,d  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Department of Health ^*  (Iraq)

^c Ibn Al Haytham Hospital   (Jordan)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFEPIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MINOCYCLINE; NITROFURANTOIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TIMENTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; BURN; BURN UNIT; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DEBRIDEMENT; DESCRIPTIVE RESEARCH; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EXCISION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; INFECTION RATE; IRAQ; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SEPSIS; SINGLE DRUG DOSE; SKIN TRANSPLANTATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; BURNS; COMPLICATION; HOSPITALIZATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BURNS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; IRAQ; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84905833839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101017     Document Type: Article

References (16)

1. Manson WL, Pernot PC, Fidler V, Sauer EW, Klasen HJ (1992) Colonization of burns and the duration of hospital stay of severely burned patients. J Hosp Infect 22: 55-63.
2. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, et al. (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.
3. Ressner RA, Murray CK, Griffith ME, Rasnake MS, Hospenthal DR, et al. (2008) Outcomes of bacteremia in burn patients involved in combat operations overseas. J Am Coll Surg 206: 439-444.
4. Rastegar Lari A, Azimi L, Rahbar M, Fallah F, Alaghehbandan R (2013) Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns 39: 174-176.
5. Ainaud P, Bertin-Maghit M, Carsin H, Le-Floch R, Perro G, et al. (2007) Recommandations relatives à l'utilisation des antibiotiques chez le brÛlé à la phase aigue. Société Française d'Etude et de Traitement des BrÛlures (SFETB). Available: http://www.sfetb.org/index.php?rub=textes-officiels&art=doc-ref-9. Accessed 2013 Jun 5.
6. Bekeris LG, Tworek JA, Walsh MK, Valenstein PN (2005) Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med 129: 1222-1225. (Pubitemid 41407424)
7. Forbes BA, Sahm DF, Weissfeld AS (2007) Bailey & Scott's Diagnostic Microbiology, 12th Edition. St Louis, Missouri: Mosby. 1056 p.
8. Clinical and Laboratory Standards Institute (2006) Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Ninth Edition. Volume 26, Number 1. M2-A9.
9. Clinical and Laboratory Standards Institute (2008) Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. M100-S18.
10. O'Brien TF, Eskildsen MA, Stelling JM (2001) Using internet discussion of antimicrobial susceptibility databases for continuous quality improvement of the testing and management of antimicrobial resistance. Clin Infect Dis 33(Suppl 3): S118-S133.
11. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, et al. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281.
12. Ressner RA, Murray CK, Griffith ME, Rasnake MS, Hospenthal DR, et al. (2008) Outcomes of bacteremia in burn patients involved in combat operations overseas. J Am Coll Surg 206: 439-444.
13. Martin MA (1993) Nosocomial infections in intensive care units: an overview of their epidemiology, outcome, and prevention. New Horiz 1: 162-171.
14. Broadhead JM, Parra DS, Skelton PA (2001) Emerging multiresistant organism in the ICU: epidemiology, risk factors, surveillance, and prevention. Crit Care Nurs Q 24: 20-29. (Pubitemid 32769469)
15. Lari AR, Panjeshahin MR, Talei AR, Rossignol AM, Alaghehbandan R (2002) Epidemiology of childhood burn injuries in Fars province, Iran. J Burn Care Rehabil 23: 39-45. (Pubitemid 34072724)
16. Othman N (2010) Epidemiology of burn injuries in Sulaymaniyah province of Iraq. PhD thesis, University of Nottingham, Nottingham, UK, April 2010.